Category: ASX Company Webcasts

Filter ASX Company Webcasts by Categories

  • ASX Company Webcasts
  • Webcast

ASX Company Webcasts

Felix Gold (ASX: FXG) Webcast Replay

21st June 2024

Live Investor Briefing

In this session Felix Gold Executive Director Joseph Webb discussed their plans to grow and develop NW Array’s 467koz resource.

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

18

Apr

Far East Gold (ASX: FEG) Webcast Replay

18th April 2024

Live Investor Briefing

In this session Far East Gold’s CEO and Director Shane Menere discussed the standout assays from our Woyla drilling campaigns that form the base of our upcoming maiden JORC resource publication.

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

Prescient Therapeutics (ASX: PTX) Webcast Replay

9th April 2024

Live Investor Briefing

In this session Prescient CEO and Managing Director Steven Yatomi-Clarke discussed why the data from their PTX-100 Phase 1b trial is so promising.

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

Pitt Street Research on Prescient Therapeutics

14th March 2024

Live Investor Briefing

Join Stuart Roberts, co-founder and senior analyst at Pitt Street Research, for an online briefing where he will outline the recent Pitt Street Research report on Prescient Therapeutics.

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

Far East Gold (ASX: FEG) Webcast Replay

22nd February 2024

Live Investor Briefing

In this session Far East Gold’s CEO and Director Shane Menere discussed, why the Board (including Nickel Industries MD Justin Werner) is optimistic about the findings so far……

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

Propell Holdings (ASX: PHL) Webcast Replay

7th February 2024

Live Investor Briefing

In this session Propell CEO Michael Davidson discussed Propell’s recent progress on the platform, cost base, and establishing a broker network…

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

19

Dec

Site Group (ASX: SIT) Webcast Replay

19th December 2023

Live Investor Briefing

In this session International Operations Director of Site Group, Vernon Wills discussed Site’s recent contract wins, growth opportunities and the key catalysts ahead.

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

Prescient Therapeutics (ASX: PTX) Webcast Replay

18th December 2023

Live Investor Briefing

In this session Prescient CEO and Managing Director Steven Yatomi-Clarke discussed the new PTX-100 Phase 1b clinical study results, following their unveiling at the American Society of Hematology (ASH) conference.

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

Wellnex Life (ASX: WNX) Webcast Replay

14th December 2023

Live Investor Briefing

In this session Wellnex Life MD Zack Bozinovski, CEO George Karafotias and new Board appointment Andrew Vidler discussed how the transformative acquisition of leading topical pain relief brand Pain Away complements Wellnex Life’s position and growth strategy whilst adding immediate scale.

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

Far East Gold (ASX: FEG) Webcast Replay

13th December 2023

Live Investor Briefing

In this session Far East Gold’s Chairman Paul Walker and GM of Exploration Mike Corey discussed the high-grade copper and gold mineralization identified through geological mapping and surface rock sampling at the Sentul and Buluroto prospect areas.

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

Felix Gold (ASX: FXG) Webcast Replay

23rd November 2023

Live Investor Briefing

In this session Felix Gold Executive Director Joseph Webb discussed Felix’s prospects in the world-class Alaskan region including high grade critical mineral antimony assays of up to 28% Sb.

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

Pitt Street Research on Prescient Therapeutics

22nd November 2023

Live Investor Briefing

Join Stuart Roberts, co-founder and senior analyst at Pitt Street Research, for an online briefing where he will outline the recent Pitt Street Research report on Prescient Therapeutics.

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

Connecting quality investors and innovative companies to facilitate mutual wealth creation with trust and transparency

Send me information on new events as they become available

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.